| Dr Cheddhi Jahan Thomas Jr, MD | |
|
3300 Gallows Rd, Falls Church, VA 22042-3307 | |
| (703) 776-4001 | |
| (703) 776-7113 |
| Full Name | Dr Cheddhi Jahan Thomas Jr |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 12 Years |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366705782 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 0101276620 (Virginia) | Secondary |
| 207ZN0500X | Pathology - Neuropathology | 0101276620 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Inova Loudoun Hospital | Leesburg, VA | Hospital |
| Inova Mount Vernon Hospital | Alexandria, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services - Pathology | 8426241647 | 34 |
| Inova Health Care Services - Pathology | 8426241647 | 34 |
News Archive
Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").
Innovative treatments for heart failure are lacking, leaving the nearly six million Americans who suffer from the condition with little hope for a cure.
GI Partners, a leading middle market private equity firm, announced today that it has completed the previously announced acquisition of Logibec, Inc., a Canadian healthcare IT company, from OMERS Private Equity.
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
› Verified 7 days ago
| Entity Name | Inova Health Care Services - Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427369578 PECOS PAC ID: 8426241647 Enrollment ID: O20101020001195 |
News Archive
Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").
Innovative treatments for heart failure are lacking, leaving the nearly six million Americans who suffer from the condition with little hope for a cure.
GI Partners, a leading middle market private equity firm, announced today that it has completed the previously announced acquisition of Logibec, Inc., a Canadian healthcare IT company, from OMERS Private Equity.
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cheddhi Jahan Thomas Jr, MD Po Box 37504, Baltimore, MD 21297-3504 Ph: (703) 321-3700 | Dr Cheddhi Jahan Thomas Jr, MD 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-4001 |
News Archive
Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").
Innovative treatments for heart failure are lacking, leaving the nearly six million Americans who suffer from the condition with little hope for a cure.
GI Partners, a leading middle market private equity firm, announced today that it has completed the previously announced acquisition of Logibec, Inc., a Canadian healthcare IT company, from OMERS Private Equity.
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
› Verified 7 days ago
Tuyethoa N. Vinh, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-3623 | |
Philip Andrew Branton, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3428 | |
Dr. Abdus Salam, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Road, Falls Church, VA 22042 Phone: 703-776-1110 | |
Roy R Zhang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Kamyar Khazaeian, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Michelle D Xia, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Lucia Pastore, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-2746 |